BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6952943)

  • 1. [Differences in leukocyte membranes detectable by a fluorescent probe in chronic leukemias].
    Baglaev TN; Kalinin NN; Dobretsov GE; Kosankova ST; Vladimirov IuA
    Biull Eksp Biol Med; 1982 Apr; 93(4):35-7. PubMed ID: 6952943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobic probe's fluorescence intensity. 3-methoxybenzanthrone (3-MBA) in bronchial asthma and urticaria patients lymphocyte membranes.
    Pytsky VI; Egorova MV; Smirnova SV
    Allergol Immunopathol (Madr); 1988; 16(4):237-42. PubMed ID: 3228044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human leukemic blood leukocyte DNA contains more breaks than normal leukocyte DNA].
    Nguyen-fiong-Ohan ; Skotnikova OI; Sevast'ianova MG; Borisov BN; Fedorov NA
    Biull Eksp Biol Med; 1980 Apr; 89(4):457-9. PubMed ID: 6930305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluorescent probe-indicator of differences between T- and B-lymphocytes in the blood].
    Dobretsov GE; Korkina LG; Val'tsel' G; Zimin IuI; Kogan EM
    Biull Eksp Biol Med; 1979 Jan; 87(1):51-3. PubMed ID: 310696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of specific immunotherapy on the structural properties of the lymphocyte membranes in atopic diseases].
    Cherkashin SIu; Nagornaia IN; Tananko EM; Dymshits LB; Nosikova TA
    Ter Arkh; 1989; 61(7):95-7. PubMed ID: 2588151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of the surface area and viscosity of membranes in T- and B-lymphocytes by means of fluorescent probes].
    Baglaev TN; Ataullakhanov RI; Dobretsov GE; Kochina IS
    Biofizika; 1983; 28(1):142-4. PubMed ID: 6600940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ryodipine--a new fluorescent probe in the determination of differences between lymphocytes].
    Belevich GV; Kosnikov VV; Dubur GIa; Dobretsov GE
    Biull Eksp Biol Med; 1989 Nov; 108(11):597-600. PubMed ID: 2633826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte chemotaxis in leukemia patients.
    Norris DA; Weston WL; Tubergen DG; Rose B; Odom LF
    J Lab Clin Med; 1980 Apr; 95(4):609-15. PubMed ID: 6965698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age characteristics of the interaction between fluorescent probes and thyroxine with the membranes of rat liver microsomes].
    Lemeshko VV
    Biofizika; 1983; 28(6):985-9. PubMed ID: 6652137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Content of 5-methylcytosine in DNA fractions in normal human leukocytes and in chronic leukoses].
    Pan'kov VN; Fedorov NA
    Vopr Med Khim; 1983; 29(2):89-92. PubMed ID: 6574653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood and marrow morphology in acute leukemia patients receiving chemotherapy: a photo-essay.
    Shafer JA
    Am J Med Technol; 1983 Feb; 49(2):77-90. PubMed ID: 6573133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative characteristics of the changes in blood lymphocyte subpopulations in chronic lympholeukemia].
    Petrov RV; Gus'kova AK; Danilova NB; Dozmorov IM; Levin AD
    Gematol Transfuziol; 1984 Nov; 29(11):21-8. PubMed ID: 6397394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differences between lymphocytes revealed by membrane fluorescent probes].
    Dobretsov GE; Kosnikov VV; Shanin SS; Kogan EM; Vladimirov IuA
    Tsitologiia; 1980 Mar; 22(3):320-5. PubMed ID: 6989060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane fluorescent probes for revealing lymphocyte population heterogeneity. II. T-and B-lymphocytes of human peripheral blood.
    Korkina LG; Dobretsov GE; Zimin YuI ; Walzel G; Kogan EM; Vladimirov YuA
    J Immunol Methods; 1982 Mar; 49(2):179-83. PubMed ID: 6978361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of purine nucleosides on human leukocytes in normal conditions and in leukemias].
    Filanovskaia LI; Blinov MN; Togo AV
    Eksp Onkol; 1987; 9(3):39-43. PubMed ID: 3608903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the peripheral blood of mice inoculated with cell-free filtrates of Graffi virus-induced leukemias.
    Niezabitowski A
    Pol Med J; 1972; 11(3):649-60. PubMed ID: 4340148
    [No Abstract]   [Full Text] [Related]  

  • 20. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.